Age, Biography and Wiki
Andrew Lees was born on 1953-02- in Massachusetts, United States, is a Vaccine chemist. Discover Andrew Lees's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 70 years old?
Popular As |
N/A |
Occupation |
Vaccine chemist |
Age |
70 years old |
Zodiac Sign |
Aquarius |
Born |
1953-02- |
Birthday |
1953-02- |
Birthplace |
Massachusetts, United States |
Nationality |
United States |
We recommend you to check the complete list of Famous People born on 1953-02-.
He is a member of famous with the age 70 years old group.
Andrew Lees Height, Weight & Measurements
At 70 years old, Andrew Lees height not available right now. We will update Andrew Lees's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
Physical Status |
Height |
Not Available |
Weight |
Not Available |
Body Measurements |
Not Available |
Eye Color |
Not Available |
Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
Family |
Parents |
Not Available |
Wife |
Not Available |
Sibling |
Not Available |
Children |
Not Available |
Andrew Lees Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Andrew Lees worth at the age of 70 years old? Andrew Lees’s income source is mostly from being a successful . He is from United States. We have estimated
Andrew Lees's net worth
, money, salary, income, and assets.
Net Worth in 2023 |
$1 Million - $5 Million |
Salary in 2023 |
Under Review |
Net Worth in 2022 |
Pending |
Salary in 2022 |
Under Review |
House |
Not Available |
Cars |
Not Available |
Source of Income |
|
Andrew Lees Social Network
Timeline
Lees worked as a magician while a graduate student at Hopkins and was featured on the cover of Baltimore Magazine, “84 People to Watch in ’84”. He successfully lobbied the Baltimore City Council, with tactics including a magic performance, resulting in a law that exempted restaurants employing “single roving performers without the use of musical instruments” from the entertainment tax.
Lees started the biotech company Fina Biosolutions LLC in 2006, where he currently serves as the CEO and Chief Scientific Officer. He was appointed an Associate Professor of Medicine at the University of Maryland School of Medicine Center for Vaccine Development in 2010. He also teaches biochromatography at the University of Maryland (College Park, Maryland)
Lees was a post-doctoral fellow (1985-1988) in the laboratory of Dr. Howard Dintzis. The work in the Dintzis’ lab centered on the Immunon model of the immune cell signaling around the synthesis of multivalent peptide constructs. He subsequently moved to the Uniformed Services University of the Health Sciences (Bethesda, MD) as a Research Instructor under Dr. Fred Finkelman and James J. Mond, although Lees’ laboratory work was in the National Institutes of Health Laboratory of Immunology headed by William E. Paul. There, under the guidance of Dr. John Inman, Lees learned bioconjugation, the linking together of biologically relevant molecules to increase their utility. In 1992, Lees set up his own lab at the Uniformed Services University and it was there that he developed the CDAP chemistry for use in conjugate vaccines. The chemistry was licensed to GlaxoSmithKline through the Henry M. Jackson Foundation. From 1993-1999, Lees was also part-time at Virion Systems, Inc. (Rockville, MD) . Lees was appointed Associate Research Professor (Department of Medicine) at USUHS in 1998 and the School cited his work in vaccines in his Meritorious Service Award (1999). From 1999-2006 Lees was Director of Macromolecular Sciences at Biosynexus, Inc.
Lees graduated from Newton North High School in 1971 as school valedictorian. He received his Bachelors of Science in Chemistry from Harvey Mudd College in 1976. After receiving his undergraduate degree Lees attended Johns Hopkins University and completed his Ph.D. in biophysics in 1984.
Andrew Lees (born February 1953 in Massachusetts, United States) is an American vaccine chemist known for developing the CDAP conjugation method, used in vaccines manufactured by GlaxoSmithKline (Streptococcus pneumoniae, Neisseria meningitidis ) and conjugate vaccines currently in clinical development by the Serum Institute of India and Chengdu Institute of Biological Products. Currently, Andrew Lees holds 25 patents in the area of conjugate vaccines.